Mode
Text Size
Log in / Sign up

Review explores gut-liver axis role in animal diseases, suggests dietary and probiotic strategies

Review explores gut-liver axis role in animal diseases, suggests dietary and probiotic strategies
Photo by Dmytro Vynohradov / Unsplash
Key Takeaway
Note: Review summarizes associative gut-liver axis evidence in animals; not directly applicable to human practice.

This systematic review article synthesizes existing evidence on the role, mechanisms, and veterinary applications of the gut-liver axis in animal diseases, specifically in ruminants, pigs, and poultry. The review describes how the gut-liver axis plays a vital role in regulating immune responses, maintaining nutritional metabolism, and preventing pathogen invasion. It reports that disruptions to intestinal barrier integrity and alterations in gut microbiota and metabolites are associated with changes in hepatic metabolism, immunity, detoxification, and systemic inflammation, contributing to the pathogenesis of various liver and metabolic disorders.

The review does not report specific intervention, comparator, or primary outcome data, nor does it provide sample sizes, follow-up duration, or study setting details. It proposes intervention strategies based on regulating the gut-liver axis, including dietary interventions, probiotics/prebiotics, and microbiota-directed modulation. It also explores the potential application of artificial intelligence and big data modeling for monitoring the gut-liver axis to develop early warning systems.

No safety, tolerability, or adverse event data from interventions are reported. The authors note the work provides novel theoretical insights and technical support for discovering multi-target bioactive compounds and advancing precision disease prevention strategies in veterinary medicine. Key limitations include the associative nature of the evidence summarized, the lack of new primary data, and the focus on animal studies, which limits direct applicability to human clinical practice. The practice relevance is restrained to providing a conceptual framework and potential strategic directions for veterinary research and preventive care.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
The liver serves as the core organ for metabolism, detoxification, and immune regulation in animals. Its functional homeostasis directly determines the animal's health status and production performance. The gut-liver axis, as a critical inter-organ regulatory network connecting the intestine and the liver, plays a vital role in regulating immune responses, maintaining nutritional metabolism balance, and preventing pathogen invasion. The review systematically elucidates the central role of the gut-liver axis in regulating metabolic homeostasis and immune defense in animals. It comprehensively integrates the structural foundations, regulatory mechanisms, and pathological functions of this axis across ruminants, pigs and poultry. It focuses on disruptions to intestinal barrier integrity and dynamic alterations in the gut microbiota and its metabolites (such as short-chain fatty acids, bile acids, etc.). These alterations directly or indirectly influence hepatic metabolism, immunity, detoxification functions and systemic inflammation, thereby contributing to the pathogenesis of various liver and related metabolic disorders. It provides intervention strategies based on gut-liver axis regulation, such as dietary interventions, probiotics/prebiotics, and microbiota-directed modulation. It also explores the application of artificial intelligence (AI) and big data modeling in monitoring the gut-liver axis with the goal of developing early warning systems. By integrating multi-omics technologies to identify key regulatory factors specific to the gut-liver axis, this work extends beyond the conventional gut-centric, single-organ framework to encompass multi-organ synergistic interactions. This approach provides novel theoretical insights and technical support for the discovery of multi-target bioactive compounds and the advancement of precision disease prevention strategies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.